## R-CYVE #2 – High risk (Group C) – CNS negative
 
**Rituximab (R)** 
-	Route: IV
-	Dosage: 375 mg/m2/dose 
-	Used on day 0
-	Caution:

**Cytarabine (ARAC)**
-	Route: IV over 12 hours
-	Dosage: 50 mg/m2/dose, in 250ml NS, continuous infusion over 12 hrs from 20h to 08h on Days 1 to 5
-	Used on Days 1 to 5

**IV high dose cytarabine (Y)**
-	Route: IV over 3 hours
-	Dosage: 3000mg/m2/dose in 250ml NS over 3 hours infusion to start after continuous infusion of cytarabine above run from 08h to 11h for 4 days

**IV etoposide (VE)**
-	Route: IV over 2 hours
-	Dosage: 200 mg/m2/dose in 500ml or 1000ml NS (maximun concentration 0.4 mg/ml), run over 2 hours at 14h to 16h for 4 days

**G-CSF**
-	Route: subcutaneously
-	Dosage: 5 mcg/kg/day
-	Used on days 7 to 21. G-CSF should be discontinued when the post nadir ANC reaches 3000/mm3, even if prior to day 21. 

